BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1945202)

  • 1. Epithelial ovarian tumors of low malignant potential.
    Massad LS; Hunter VJ; Szpak CA; Clarke-Pearson DL; Creasman WT
    Obstet Gynecol; 1991 Dec; 78(6):1027-32. PubMed ID: 1945202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of pathologic features and treatment modalities in ovarian tumors of low malignant potential.
    Hopkins MP; Kumar NB; Morley GW
    Obstet Gynecol; 1987 Dec; 70(6):923-9. PubMed ID: 3684131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic importance of intraoperative rupture of malignant ovarian epithelial neoplasms.
    Sainz de la Cuesta R; Goff BA; Fuller AF; Nikrui N; Eichhorn JH; Rice LW
    Obstet Gynecol; 1994 Jul; 84(1):1-7. PubMed ID: 8008300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical staging of ovarian low malignant potential tumors.
    Rao GG; Skinner E; Gehrig PA; Duska LR; Coleman RL; Schorge JO
    Obstet Gynecol; 2004 Aug; 104(2):261-6. PubMed ID: 15291997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules.
    Provenza C; Young RH; Prat J
    Am J Surg Pathol; 2008 Mar; 32(3):383-9. PubMed ID: 18300813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically apparent early stage invasive epithelial ovarian carcinoma: should all be treated similarly?
    Le T; Krepart GV; Lotocki RJ; Heywood MS
    Gynecol Oncol; 1999 Aug; 74(2):252-4. PubMed ID: 10419740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment and prognostic factors for stage IV epithelial ovarian cancer].
    Wu M; Shen K; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial ovarian tumors of borderline malignancy: long-term follow-up.
    Casey AC; Bell DA; Lage JM; Fuller AF; Nikrui N; Rice LW
    Gynecol Oncol; 1993 Sep; 50(3):316-22. PubMed ID: 8406194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective cohort study of surgical staging for ovarian low malignant potential tumors.
    Wingo SN; Knowles LM; Carrick KS; Miller DS; Schorge JO
    Am J Obstet Gynecol; 2006 May; 194(5):e20-2. PubMed ID: 16647891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian epithelial tumors of low malignant potential.
    Chien RT; Rettenmaier MA; Micha JP; DiSaia PJ
    Surg Gynecol Obstet; 1989 Aug; 169(2):143-6. PubMed ID: 2756462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage I epithelial ovarian tumors of low malignant potential.
    Sawada M; Yamasaki M; Urabe T; Hashimoto K; Katayama S
    Jpn J Clin Oncol; 1991 Feb; 21(1):30-4. PubMed ID: 2067119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
    Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian serous neoplasms of low malignant potential associated with focal areas of serous carcinoma.
    Silva EG; Tornos CS; Malpica A; Gershenson DM
    Mod Pathol; 1997 Jul; 10(7):663-7. PubMed ID: 9237175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors.
    Prayson RA; Hart WR; Petras RE
    Am J Surg Pathol; 1994 Jun; 18(6):591-603. PubMed ID: 8179074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility-sparing surgery for ovarian low malignant potential tumors.
    Rao GG; Skinner EN; Gehrig PA; Duska LR; Miller DS; Schorge JO
    Gynecol Oncol; 2005 Aug; 98(2):263-6. PubMed ID: 15964063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serous and mucinous ovarian cystadenomas at the limit of malignancy].
    Chenevart P; Gloor E
    Schweiz Med Wochenschr; 1980 Apr; 110(14):531-9. PubMed ID: 7375903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.